Non-ST elevation myocardial infarction (NSTEMI) represents a significant clinical entity within the spectrum of acute ...
Frye Regional Medical Center, a Duke LifePoint hospital and Duke Health Affiliate in Heart, has earned national recognition ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
The DanGer shock criteria were first introduced in the landmark DanGer Shock trial, which demonstrated a survival advantage from early Impella support in patients with ST-elevation myocardial ...
Hendrick Medical Center Brownwood has received the American Heart Association’s Get With The Guidelines® – Coronary Artery Disease Rural Recognition Bronze awards for its commitment to offering rapid, ...
Clinical guidelines recommend different revascularization strategies for nonculprit lesions in patients with ST-segment–elevation myocardial infarction (STEMI) versus non-STEMI (NSTEMI). Whether the ...
Monocytes are heterogeneous immune cells that play a crucial role in the inflammatory response during atherosclerosis, influencing the progression and outcome of the disease. In the pathogenesis of ...
Lower risk for bleeding without increase in ischemic events seen for patients with acute coronary syndrome. HealthDay News — For patients with acute coronary syndrome (ACS) undergoing drug-eluting ...
The conventional classification of acute myocardial infarction (AMI) into ST-segment elevation (STEMI) and non-ST-segment elevation (NSTEMI) has long guided clinical decision-making. However, emerging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback